| Overview |
| bsm-0968m-pbs-only-100ul |
| Alpha-Synuclein Monoclonal Antibody, PBS Only Conjugated |
| IHC-P, IHC-F, IF(IHC-P) |
| Human |
| Specifications |
| PBS Only |
| Rabbit |
| KLH conjugated synthetic peptide derived from human Alpha-Synuclein |
| Monoclonal |
| 7B7 |
| IgG |
| 1ug/ul |
| Purified by Protein G. |
| PBS (pH=7.4) |
| Store at 4°C for 12 months. |
| Target |
| 6622 |
| P37840 |
| Cytoplasm, Nucleus, Cell membrane |
| Alpha synuclein; Alpha-synuclein, isoform NACP140; alpha SYN; MGC105443; MGC110988; MGC127560; MGC64356; NACP; Non A beta component of AD amyloid; Non A4 component of amyloid precursor; Non-A-beta component of alzheimers disease amyloid , precursor of; Non-A beta component of AD amyloid; Non-A4 component of amyloid precursor; PARK 1; PARK 4; PARK1; PARK4; Parkinson disease (autosomal dominant, Lewy body) 4; Parkinson disease familial 1; PD 1; PD1; Syn; SNCA; Snca synuclein, alpha (non A4 component of amyloid precursor); SYUA_HUMAN; Synuclein alpha; Synuclein, alpha (non A4 component of amyloid precursor); |
| May be involved in the regulation of dopamine release and transport. Induces fibrillization of microtubule-associated protein tau. Reduces neuronal responsiveness to various apoptotic stimuli, leading to a decreased caspase-3 activation. |
| Application Dilution |
| IHC-P |
1:100-500 |
| IHC-F |
IHC-F1:100-500 |
| IF(IHC-P) |
IFIHC-P1:100-500 |
Powered by Bioz